These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36682208)

  • 1. Long-term vs short-term tocolysis with ritodrine hydrochloride: Propensity score-matched analysis.
    Okuda A; Inayama Y; Mizuno K; Takeuchi M; Kawakami K; Mandai M; Higuchi T
    Eur J Obstet Gynecol Reprod Biol; 2023 Mar; 282():77-82. PubMed ID: 36682208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of ritodrine hydrochloride for the treatment of preterm labour: a systematic review.
    Yaju Y; Nakayama T
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):813-22. PubMed ID: 16981213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of maintenance tocolysis with nifedipine in established preterm labour on pregnancy prolongation and neonatal outcome.
    Aggarwal A; Bagga R; Girish B; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Feb; 38(2):177-184. PubMed ID: 28784001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.
    Han S; Crowther CA; Moore V
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000940. PubMed ID: 23728634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between total dose of ritodrine hydrochloride and pulmonary oedema in twin pregnancy: a retrospective cohort study in Japan.
    Shinohara S; Sunami R; Uchida Y; Hirata S; Suzuki K
    BMJ Open; 2017 Dec; 7(12):e018118. PubMed ID: 29289935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.
    Han S; Crowther CA; Moore V
    Cochrane Database Syst Rev; 2010 Jul; (7):CD000940. PubMed ID: 20614423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal admission characteristics as risk factors for preterm birth.
    Papatsonis DN; van Geijn HP; Bleker OP; Ader HJ; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 2004 Jan; 112(1):43-8. PubMed ID: 14687737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.
    Van De Water M; Kessel ET; De Kleine MJ; Oei SG
    Acta Obstet Gynecol Scand; 2008; 87(3):340-5. PubMed ID: 18307075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.
    Parry E; Roos C; Stone P; Hayward L; Mol BW; McCowan L
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):231-6. PubMed ID: 24506318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocolysis compared with no tocolysis in women with threatened preterm birth and ruptured membranes: A propensity score analysis.
    van Winden TMS; Roos C; Nijman TAJ; Kleinrouweler CE; Olaru A; Mol BW; McAuliffe FM; Pajkrt E; Oudijk MA
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():67-73. PubMed ID: 33096392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate use of ritodrine hydrochloride for threatened preterm birth in Japan: a retrospective cohort study using a national inpatient database.
    Shigemi D; Aso S; Yasunaga H
    BMC Pregnancy Childbirth; 2019 Jun; 19(1):204. PubMed ID: 31215479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory and infectious risk factors are associated with the response to tocolysis in patients with preterm labor.
    Torricelli M; Voltolini C; Conti N; De Bonis M; Biliotti G; Picciolini E; Petraglia F
    J Matern Fetal Neonatal Med; 2011 Jan; 24(1):43-6. PubMed ID: 20586546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.
    Martinez de Tejada B; Karolinski A; Ocampo MC; Laterra C; Hösli I; Fernández D; Surbek D; Huespe M; Drack G; Bunader A; Rouillier S; López de Degani G; Seidenstein E; Prentl E; Antón J; Krähenmann F; Nowacki D; Poncelas M; Nassif JC; Papera R; Tuma C; Espoile R; Tiberio O; Breccia G; Messina A; Peker B; Schinner E; Mol BW; Kanterewicz L; Wainer V; Boulvain M; Othenin-Girard V; Bertolino MV; Irion O;
    BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocolysis in the management of preterm prelabor rupture of membranes at 22-33 weeks of gestation: study protocol for a multicenter, double-blind, randomized controlled trial comparing nifedipine with placebo (TOCOPROM).
    Lorthe E; Kayem G;
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):614. PubMed ID: 34496799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal corticosteroid administration in women undergoing tocolytic treatment who delivered before 34 weeks of gestation: a retrospective cohort study using a national inpatient database.
    Shigemi D; Yasunaga H
    BMC Pregnancy Childbirth; 2019 Jan; 19(1):17. PubMed ID: 30626359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine versus placebo in the treatment of preterm prelabor rupture of membranes: a randomized controlled trial: Assessment of perinatal outcome by use of tocolysis in early labor-APOSTEL IV trial.
    Nijman TA; van Vliet EO; Naaktgeboren CA; Oude Rengerink K; de Lange TS; Bax CJ; Bloemenkamp KW; van Eyck J; Kok M; Scheepers HC; Woiski M; Franx A; Mol BW; Oudijk MA
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():79-84. PubMed ID: 27567363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between prolonged gestation and nifedipine pharmacokinetics in long-term tocolysis.
    Tamura M; Murata S; Ota C; Tanaka S; Arichika H; Hakuno D; Okada N; Ushijima K; Tsuji Y; Kitahara T
    Basic Clin Pharmacol Toxicol; 2024 Feb; 134(2):241-249. PubMed ID: 37987176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocolysis after preterm prelabor rupture of membranes and 5-year outcomes: a population-based cohort study.
    Lorthe E; Marchand-Martin L; Letouzey M; Aubert AM; Pierrat V; Benhammou V; Delorme P; Marret S; Ancel PY; Goffinet F; L'Hélias LF; Kayem G;
    Am J Obstet Gynecol; 2024 May; 230(5):570.e1-570.e18. PubMed ID: 37827270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocolytic Treatment for the Prevention of Preterm Birth from a Taiwanese Perspective: A Survey of Taiwanese Obstetric Specialists.
    Lee HH; Yeh CC; Yang ST; Liu CH; Chen YJ; Wang PH
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35409902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mathematical model for predicting outcome in preterm labour.
    Takagi K; Satoh K; Muraoka M; Takagi K; Seki H; Nakabayashi M; Takeda S; Yoshida K; Nishioka N; Ikenoue T; Kanayama N; Kanzaki T; Sagawa T; Matsuda Y
    J Int Med Res; 2012; 40(4):1459-66. PubMed ID: 22971497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.